WHO ICTRP trial
BEHANDLING AF BASALCELLE KARCINOMER MED METHYL AMINOLEVULINAT OG DAGSLYS
EUCTR2010-024517-31-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-024517-31-DK |
|---|---|
| Public title | BEHANDLING AF BASALCELLE KARCINOMER MED METHYL AMINOLEVULINAT OG DAGSLYS |
| Scientific title | BEHANDLING AF BASALCELLE KARCINOMER MED METHYL AMINOLEVULINAT OG DAGSLYS |
| Primary sponsor | Hans Christian Wulf |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Basal celle carcinomer MedDRA version: 12.1 Level: LLT Classification code 10004146 Term: Basal cell carcinoma |
| Interventions | Trade Name: Metvix Product Name: Metvix Pharmaceutical Form: Cream INN or Proposed INN: methyl aminolevulinate CAS Number: 33320-16-0 Other descriptive name: METHYL AMINOLEVULINATE Concentration unit: % (W/W) percent weight/weight… |
| Registration date | Apr 2, 2011 |
| Target size | 30 |
| Secondary IDs | 16-12-2010ver1.0 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: